» Articles » PMID: 15505253

Rofecoxib (Vioxx) Voluntarily Withdrawn from Market

Overview
Journal CMAJ
Date 2004 Oct 27
PMID 15505253
Citations 41
Authors
Affiliations
Soon will be listed here.
Citing Articles

Pyrazoles as Anti-inflammatory and Analgesic Agents: and Studies.

Chahal G, Monga J, Rani I, Saini S, Devgun M, Husain A Antiinflamm Antiallergy Agents Med Chem. 2024; 23(1):39-51.

PMID: 38828869 DOI: 10.2174/0118715230275741231207115011.


Characteristics of adverse drug reactions due to nonsteroidal anti-inflammatory drugs: a cross-sectional study.

Sonsupap C, Pokhakul P, Kariya T, Suzuki Y, Hamajima N, Yamamoto E Nagoya J Med Sci. 2023; 85(4):668-681.

PMID: 38155619 PMC: 10751502. DOI: 10.18999/nagjms.85.4.668.


Lipid Nano-System Based Topical Drug Delivery for Management of Rheumatoid Arthritis: An Overview.

Dhule K, Nandgude T Adv Pharm Bull. 2023; 13(4):663-677.

PMID: 38022817 PMC: 10676558. DOI: 10.34172/apb.2023.075.


Risk/benefit trade-offs in rheumatology: rofecoxib revisited in the era of JAK inhibitors.

Hazlewood G Rheumatology (Oxford). 2023; 62(12):3773-3775.

PMID: 37531287 PMC: 10691927. DOI: 10.1093/rheumatology/kead388.


Efficacy of Ibuprofen after Total Hip Arthroplasty to Prevent Heterotopic Ossification: Systematic Review and Meta-Analysis.

Tariq M, Ahmed B, Shaikh S, Amin H, Ali S Rev Bras Ortop (Sao Paulo). 2023; 58(3):378-387.

PMID: 37396093 PMC: 10310429. DOI: 10.1055/s-0042-1748947.